Search Results - "Nomoto, M."

Refine Results
  1. 1

    Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats by Afrin, R, Arumugam, S, Soetikno, V, Thandavarayan, R A, Pitchaimani, V, Karuppagounder, V, Sreedhar, R, Harima, M, Suzuki, H, Miyashita, S, Nomoto, M, Suzuki, K, Watanabe, K

    Published in Free radical research (01-03-2015)
    “…We investigated the effect of curcumin on liver injury in diabetic rats induced by streptozotocin (STZ) through modulation of endoplasmic reticulum stress…”
    Get more information
    Journal Article
  2. 2

    Regular Immunological Evaluations for Progression of Cardiac Allograft Vasculopathy by Hattori, H., Nomoto, M., Imamura, Y., Kikuchi, N., Ichihara, Y., Saito, S., Niinami, H., Hagiwara, N., Nunoda, S.

    “…The methods for detection of post-transplant rejection, especially antibody-mediated rejection (AMR) have been developed for the past three decades and…”
    Get full text
    Journal Article
  3. 3

    Promoter CpG methylation in cancer cells contributes to the regulation of MUC4 by Yamada, N, Nishida, Y, Tsutsumida, H, Goto, M, Higashi, M, Nomoto, M, Yonezawa, S

    Published in British journal of cancer (27-01-2009)
    “…Mucin 4 (MUC4) is a high molecular weight transmembrane mucin that is overexpressed in many carcinomas and is a risk factor associated with a poor prognosis…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Zonisamide up-regulated the mRNAs encoding astrocytic anti-oxidative and neurotrophic factors by Choudhury, ME, Sugimoto, K, Kubo, M, Iwaki, H, Tsujii, T, Kyaw, WT, Nishikawa, N, Nagai, M, Tanaka, J, Nomoto, M

    Published in European journal of pharmacology (15-08-2012)
    “…Zonisamide has been proven as an effective drug for the recovery of degenerating dopaminergic neurons in the animal models of Parkinson's disease. However,…”
    Get full text
    Journal Article
  7. 7

    Plasma amantadine concentrations in patients with Parkinson's disease by Nishikawa, N, Nagai, M, Moritoyo, T, Yabe, H, Nomoto, M

    Published in Parkinsonism & related disorders (01-06-2009)
    “…Abstract We determined plasma amantadine concentrations in patients with Parkinson's disease (PD) in daily clinical practice and investigated the relationship…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma by Matsukita, S, Nomoto, M, Kitajima, S, Tanaka, S, Goto, M, Irimura, T, Kim, Y S, Sato, E, Yonezawa, S

    Published in Histopathology (01-01-2003)
    “…Aims:  Mucinous carcinoma of the breast usually shows less frequent lymph node metastasis and more favourable outcome compared with invasive ductal carcinoma…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Delayed l-DOPA-induced hyperalgesia by Shimizu, T., Iwata, S., Miyata, A., Fukuda, T., Nomoto, M.

    Published in Pharmacology, biochemistry and behavior (01-11-2006)
    “…Previously we reported on l-DOPA's antinociceptive effect on substance P-induced nociceptive behaviors in mice [Shimizu T, Iwata S, Morioka H, Masuyama T,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Structural Effects of O-Glycosylation on a 15-Residue Peptide from the Mucin (MUC1) Core Protein by Kirnarsky, Leo, Prakash, Om, Vogen, Shawn M, Nomoto, Mitsuharu, Hollingsworth, Michael A, Sherman, Simon

    Published in Biochemistry (Easton) (03-10-2000)
    “…To study the effect of O-glycosylation on the conformational propensities of a peptide backbone, the 15-residue peptide PPAHGVTSAPDTRPA (PPA15) from the MUC1…”
    Get full text
    Journal Article
  15. 15

    Effect of grapefruit juice on cabergoline pharmacokinetics in patients with Parkinson's disease by Nagai, M., Nakatsuka, A., Yabe, H., Moritoyo, T., Nomoto, M.

    Published in Clinical pharmacology and therapeutics (01-02-2005)
    “…Background Cabergoline is one of the synthetic ergoline dopamine agonists, which is widely used for the treatment of Parkinson's disease (PD). Cytochrome P‐450…”
    Get full text
    Journal Article
  16. 16

    A CYP3A4 inhibitor increased the effect of cabergoline in the treatment of Parkinson's disease by Nakatsuka, A., Nagai, M., Yabe, H., Moritoyo, T., Nomoto, M.

    Published in Clinical pharmacology and therapeutics (01-02-2005)
    “…Introduction Cabergoline is a synthetic ergote dopamine agonist that is metabolized by CYP3A4, is applied in the treatment of Parkinson's disease (PD)…”
    Get full text
    Journal Article
  17. 17

    Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers and patients with parkinson's disease by Nomoto, M., Nomura, T., Nakatsuka, A., Nagai, M., Yabe, Y.

    Published in Clinical pharmacology and therapeutics (01-02-2004)
    “…Pharmacokinetic interaction between cabergoline, a dopamine receptor agonist and a macrolide, clarithromycin was studied in healthy volunteers and patients…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Morphological and functional characterization of hemocytes in the giant clam Tridacna crocea by NAKAYAMA, K, NOMOTO, A. M, NISHIJIMA, M, MARUYAMA, T

    Published in Journal of invertebrate pathology (01-03-1997)
    “…In order to understand the cellular defense system in the giant clam Tridacna crocea, which harbors symbiotic microalga zooxanthella, hemocytes of the giant…”
    Get full text
    Journal Article
  20. 20

    Circulating immunoglobulin‐bound transforming growth factor β at a late tumour‐bearing stage impairs antigen‐specific responses of CD4+ T cells by HARADA, M., TATSUGAMI, K., NOMOTO, M., NOMOTO, K.

    Published in Clinical and experimental immunology (01-05-2002)
    “…SUMMARY In order to elucidate the mechanisms by which tumour‐specific CD4+ T‐cell responses are impaired during tumour development, an attempt was made to…”
    Get full text
    Journal Article